Samsara Vision

12/23/2025

⁉️What design improvements have been implemented in the second generation Implantable Miniature Telescope (IMT)?

In this episode of Innovations in Surgical Retina, Prof. David Keegan leads a discussion about the second generation device and what makes it safer and easier to implant compared to the original IMT, while yielding comparable results for patients.

In this episode of Innovations in Surgical Retina, Prof. David Keegan leads a discussion about the Implantable Miniature Telescope (IMT), the first and only device demonstrated to improve vision and quality of life in patients with late-stage AMD. Prof....

12/17/2025

🔦CONCERTO Site Spotlight: Ridge Eye Care in Northern California recently performed their first successful SING IMT®️ implant. The team at Ridge Eye Care says they are excited to be part of the study and to collaborate with Samsara Vision.

Thank you to Dr. Spencer, Dr. Mennucci, Yasmin, and Christy for helping late-stage AMD patients regain their vision and improve their quality of life.

12/16/2025

This holiday season, we are so grateful for these heartwarming SING IMT®️ stories. We’re also grateful for the caregivers, clinicians, and advocates that are fighting to improve vision for individuals with untreatable retinal disorders.

Tag someone you think would be grateful to see this video. 🙏

12/12/2025

From all of us at Samsara Vision, we hope you have a wonderful holiday season!

12/11/2025

Last week the Samsara U.S. and Samsara Vision Europe team attended FLORETINA.

Swipe to relive the experience with us, including the live SING IMT®️surgery.

Thank you to everyone who attended on behalf of Samsara and those who stopped by our booth and presentations to learn about our innovative intraocular telescope.

12/04/2025

Lucky 13! Last month, Samsara Vision announced that there are now thirteen Concerto clinical trials sites across the United States and Puerto Rico.

Welcome to our new sites:
• Cincinnati Eye Institute (Cincinnati, OH) – Principal Investigator: Michael Snyder, MD
• Georgia Eye Partners (Woodstock, GA) – Principal Investigator: Evan Schoenberg, MD
• North Valley Eye Care (Chico, CA) – Principal Investigator: Terrence Spencer, MD
• Instituto de Ojos (Carolina, PR) – Principal Investigator: Miguel Santiago, MD

The addition of these sites is a reflection of our commitment to advancing treatment options for patients with late-stage AMD.

Where should Concerto go next?

11/20/2025

SAMSARA VISION MILESTONE! We are proud to recognize Evan D. Schoenberg, M.D. and his truly dedicated team at Georgia Eye Partners for performing the first implantation of the SING IMT®️ in the state of Georgia.

We commend Dr. Schoenberg’s leadership and commitment to advancing options for patients diagnosed with late-stage AMD.

11/19/2025

How exactly does the SING IMT®️ work? Dr. Carlos E. Martinez, MD, MS explains in this clip.

💭 What would you or your loved one with late-stage AMD be most excited about seeing again?

11/06/2025

We love to hear these powerful SING IMT®️ moments from clinicians like Dr. Carlos E. Martinez, MD, MS.

11/04/2025

ICYMI, we recently announced the initiation and the first surgery of the PERSPECTIVE clinical trial to evaluate the efficacy and safety of the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT ®) in pseudophakic patients.

On September 30, 2025, Dr. John Conrath, a leading vitreoretinal and cataract surgeon at Centre Monticelli-Paradis, Marseille, France, conducted the first procedure.

Thank you, Dr. Conrath, for sharing your insights.

10/31/2025

What makes the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT ® ) different from the first generation IMT? Samsara’s Rebecca Kammer speaks with Dr. Carlos E. Martinez, MD, MS about the improvements in the second generation device.

10/27/2025

Last week, Samsara Vision was honored to welcome to our office in Far Hills, New Jersey. Mr. Kean represents the 7th district of NJ, where Samsara Vision HQ is located.

During his visit, Mr. Kean learned about the Samsara Vision story and our mission to bring freedom and vision back to people around the world living with late-stage AMD. We also talked about opportunities to work together within the federal government framework.

Mr. Kean featured his visit to Samsara Vision in his weekly constituent newsletter, thanking us for our commitment to advancing life-changing innovation in eye care.

This visit was truly an honor, and we are fortunate to have such a dedicated congressman representing us in Washington, D.C.